| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
12,090,000 |
| Market
Cap: |
2.37(M) |
| Last
Volume: |
4,012,246 |
Avg
Vol: |
4,001,203 |
| 52
Week Range: |
$0.1961 - $0.4503 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aethlon Medical is a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases. The Aethlon Hemopurifier® (Hemopurifier) is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. Co. is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Broenniman Edward G |
Director |
– • – |
2010-04-09 |
4 |
AS |
$0.33 |
$4,150 |
D/D |
(12,500) |
299,574 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-04-08 |
4 |
AS |
$0.34 |
$4,188 |
D/D |
(12,500) |
312,074 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-04-07 |
4 |
AS |
$0.35 |
$4,200 |
D/D |
(12,000) |
324,574 |
|
- |
|
| Barry Franklyn S Jr |
Director |
– • – |
2010-04-07 |
4 |
AS |
$0.35 |
$1,540 |
D/D |
(4,400) |
106,593 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-04-06 |
4 |
AS |
$0.35 |
$4,165 |
D/D |
(11,900) |
336,574 |
|
- |
|
| Barry Franklyn S Jr |
Director |
– • – |
2010-04-06 |
4 |
AS |
$0.35 |
$4,165 |
D/D |
(11,900) |
110,993 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-04-05 |
4 |
AS |
$0.35 |
$4,037 |
D/D |
(11,500) |
348,474 |
|
- |
|
| Barry Franklyn S Jr |
Director |
– • – |
2010-04-05 |
4 |
AS |
$0.35 |
$4,037 |
D/D |
(11,500) |
122,893 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-04-01 |
4 |
AS |
$0.37 |
$4,218 |
D/D |
(11,400) |
359,974 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-31 |
4 |
AS |
$0.37 |
$4,015 |
D/D |
(11,000) |
371,374 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-30 |
4 |
AS |
$0.38 |
$4,180 |
D/D |
(11,000) |
382,374 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-29 |
4 |
AS |
$0.39 |
$4,290 |
D/D |
(11,000) |
393,374 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-26 |
4 |
AS |
$0.41 |
$4,100 |
D/D |
(10,000) |
404,374 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-25 |
4 |
AS |
$0.45 |
$4,050 |
D/D |
(9,000) |
414,374 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-24 |
4 |
AS |
$0.39 |
$3,120 |
D/D |
(8,000) |
423,374 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-23 |
4 |
AS |
$0.39 |
$3,003 |
D/D |
(7,700) |
431,374 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-22 |
4 |
AS |
$0.39 |
$2,965 |
D/D |
(7,700) |
439,074 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-19 |
4 |
AS |
$0.39 |
$2,886 |
D/D |
(7,400) |
446,774 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-18 |
4 |
AS |
$0.38 |
$2,736 |
D/D |
(7,200) |
454,174 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-17 |
4 |
AS |
$0.41 |
$2,890 |
D/D |
(7,100) |
461,374 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-16 |
4 |
AS |
$0.39 |
$2,730 |
D/D |
(7,000) |
468,474 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2010-03-15 |
4 |
AS |
$0.38 |
$2,546 |
D/D |
(6,700) |
475,474 |
|
- |
|
| Joyce James A |
Chair., Pres., CEO, CFO, Sec. |
• • • |
2009-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
300,000 |
400,000 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2009-11-25 |
4 |
S |
$0.35 |
$35,350 |
D/D |
(100,000) |
482,174 |
|
- |
|
| Tullis Richard |
VP, Chief Science Officer |
• • – |
2008-07-31 |
4 |
A |
$0.32 |
$150,000 |
D/D |
468,750 |
526,750 |
|
- |
|
181 Records found
|
|
Page 7 of 8 |
|
|
